1-3 of 3
Christoph Medler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results

Georg Hess, MD, Wagner Karola, Paul LaRosee, MD, Ulrich Keller, Johannes Atta, Mathias Witzens-Harig, MD, Anne Crombé, Christoph Medler, Peter Borchmann, MD, Ulrich Bitz, MD, Christian Lerchenmüller, MD, Matthias Theobald, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2977.
https://doi.org/10.1182/blood.V128.22.2977.2977
Published: 2016
Journal Articles

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial

Georg Hess, MD, Ulrich Keller, Johannes Atta, Ulrich Bitz, MD, Christian Lerchenmueller, Wagner Karola, Christoph Medler, Christian Ruckes, Mathias Witzens-Harig, MD, Kai Huebel, Paul LaRosee, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3930.
https://doi.org/10.1182/blood.V126.23.3930.3930
Published: 2015
Journal Articles

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial

Georg Hess, MD, Ulrich Keller, MD, Johannes Atta, Christian Buske, Peter Borchmann, MD, Christoph Medler, Mathias Witzens-Harig, Martin H. Dreyling, PhD
Journal: Blood
Blood (2011) 118 (21): 2697.
https://doi.org/10.1182/blood.V118.21.2697.2697
Published: 2011